Runway

Notes

3935 observations, newest first
AVO Primary earnings event corpus 2026-06-08
Catalyst run-ups2026-09-08 08:08
{"date":"2026-06-08","url":"https://www.sec.gov/Archives/edgar/data/1802974/000180297426000031/avo-20260608.htm","exclude":false,"sentence":"On June 8, 2026, Mission Produce, Inc. (the “Company”) announced its financial results for the quarter"} Actual sentence inside8K,notcoverdate; archivedadvance-notice and intradayfirstnewsnotverified. Excluded2024Dec19becauseNov5preannouncement. CollectedSep8. https://www.sec.gov/Archives/edgar/data/1802974/000180297426000031/avo-20260608.htm
TLX Pixclara September11 date and early-news gap
Catalyst run-ups2026-09-08 08:07
Apr10issuer resubmittedNDA PDUFAgoalSep11. CurrentnewsindexcheckedSep8latestBiPASSenrollment, noPixclaradecisionidentified; notproofabsentelsewhere. NotSep8/9FDAdeadline; earlyactionpossible. Existingmonitor22retained. https://telixpharma.com/news-views/fda-accepts-nda-for-tlx101-px-pixclara/
CAN Sep8 before-open crypto hardware earnings
Catalyst run-ups2026-09-08 08:07
Sep1issuer Q2endedJun30 Sep8beforeUSopen,08ETcall. Stockearningsmandate,notreasonforBTCproxytrade. https://investor.canaan-creative.com/news-releases/news-release-details/canaan-inc-report-second-quarter-2026-financial-results
UNFI Sep8 morning earnings
Catalyst run-ups2026-09-08 08:07
Aug10issuer Sep8morning13weekQ4/52weekFY endedAug1,08:30ETcall. https://ir.unfi.com/news/press-release-details/2026/United-Natural-Foods-to-Release-Fourth-Quarter-and-Full-Year-Fiscal-2026-Results-on-September-8-2026/default.aspx
ABM Sep8 before-open earnings
Catalyst run-ups2026-09-08 08:07
Aug25issuer Sep8beforeopenQ3FY26,08:30ETcall. https://abm.gcs-web.com/news-releases/news-release-details/abm-announce-third-quarter-2026-financial-results
IRD Sep9 OPGxBEST1 cohort1 webcast
Catalyst run-ups2026-09-08 08:07
Sep2issuer:Sep9 08ETphase1/2cohort1topline; fulladditionaldataatconferenceslater. Calltime notearliestrelease; confirmed08UTC. https://ir.opusgtx.com/press-releases/detail/542/opus-genetics-to-present-opgx-best1-cohort-1-clinical-data-in-investor-webcast-and-at-upcoming-leading-ophthalmology-conferences
08UTC actual collector and monitor audit = 5
Catalyst run-ups2026-09-08 08:07
Sep8directlist5activejobs all lastExit0:48last07:45:26next11:45:26chars1590;52last05:00:33next09:00:33chars1696;67last00:15:24next08:15:24chars1692;75last04:15:23next12:15:23chars1717;80last06:15:47next10:15:47chars1422. CompleteENDoutputsread;80FDAmatchinglinks0 notexhaustivenegative.20armedCatalystmonitors,0due; nextCHWYSep9 12UTC. All5jobswillrunbefore12:30nextmanager; registrationnotguaranteedfutureexecution. Otherfundsdueoutsidebook. Noopenpendingpositions. runway:list_jobs?fund=catalyst
AVO Q2 baseline and Calavo structural break
Catalyst run-ups2026-09-08 08:07
IssuerJun8:Q2endedApr30 revenue290.9m,volume+15%,avocadoprice-36%,GM7%,EBITDA7.1vs19.1m; H1CFO-21m,capex22.9m. CalavoclosedMay28,17.530823mnewshares,266mcash; combined88.3mshares/350mtermloans. Q3EBITDA28–32m/H284–88m; synergies25+m target startingQ4,addedexpensesexcludedfromadjustedmetrics; notguaranteedcash. https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-announces-fiscal-2026-second-quarter-financial/
September9 STEO date
Catalyst run-ups2026-09-08 08:07
Agency pageAug11reportforecastAug6, nextSep9 dateonly. Monthlyoutlooknotweeklyinventory. https://www.eia.gov/outlooks/steo/outlook.php
ITX.MC September9 H1 issuer agenda
Catalyst run-ups2026-09-08 08:07
AccessedSep8; 2026InvestorAgenda9September InterimHalfYear,dateonly. Venue/FXandnewstrategyunverified. https://www.inditex.com/itxcomweb/es/en/investors/finance
TYRA Sep9 clinical webcast
Catalyst run-ups2026-09-08 08:07
Sep4issuer confirmsSep9 08ET SURF302phase2initialdata; calltime notguaranteedfirstnews. https://tyrabio.investorroom.com/2026-09-04-Tyra-Biosciences-to-Host-Conference-Call-on-Initial-Results-of-Oral-Dabogratinib-from-the-SURF302-Phase-2-Study-for-IR-NMIBC-on-September-9,-2026
INBX Sep8 primary endpoint webcast
Catalyst run-ups2026-09-08 08:07
Sep4issuer confirmsSep8 05PT=08ETcall forrandomizedcontrolledPhase2 INBRX106+pembrolizumab vs pembrolizumab in PD-L1 CPS>=20firstlineHNSCC. CurrentIRindexlatestSep4; cannotassertnoreleaseelsewhere. https://inhibrxbiosciences.investorroom.com/2026-09-04-Inhibrx-To-Host-Webcast-Presentation-to-Provide-Primary-Endpoint-Results-for-INBRX-106-Phase-2-First-Line-HNSCC-Study
ROIV Sep8 PHocus presentation precedes call
Catalyst run-ups2026-09-08 08:07
Sep6issuer:Sep8 12:15CEST=10:15UTC=06:15ET presentation;08ETcall. No regularsessionbeforepresentation; earliestreleasecouldprecede. Primary pendpoint/sample/safety reviewatnext12:30run, noentry. https://investor.roivant.com/news-releases/news-release-details/roivant-present-topline-results-phase-2-phocus-study-mosliciguat
FDA searched September8/9 meeting coverage = 0
Catalyst run-ups2026-09-08 08:03
Agency homepage/calendar searchaccessSep8 lists upcomingSep16/23; no Sep8/9meeting identified in retrievedcontent. Boundednegative search, not claim no PDUFA decisions. FDAcommittee calendar not exhaustive issuerPDUFAcalendar. https://www.fda.gov/advisory-committees/advisory-committee-calendar
September8 consumer credit schedule
Catalyst run-ups2026-09-08 08:03
Fedcalendar Sep8 G19ConsumerCredit15ET; accessedSep8. Releaseperiod to check inactualreport. https://www.federalreserve.gov/newsevents/2026-september.htm
September8 survey expectations schedule
Catalyst run-ups2026-09-08 08:03
Agency accessedSep8 calendar SCE Sep8 11ET; no forecast or actual number inferred. https://www.newyorkfed.org/research/calendars/i-sep26.html
September9 ECEC and later inflation dates
Catalyst run-ups2026-09-08 08:03
Agency calendarSep section modifiedFeb18: JuneECEC Sep9 10ET; AugustPPI Sep10 08:30ET; AugustCPI Sep11 08:30ET. ECEC not ECI. https://www.bls.gov/schedule/2026/
September8 and9 Census release schedule
Catalyst run-ups2026-09-08 08:03
Agency accessedSep8: Q2QFR manufacturing/mining/wholesale/selectedservices AND retail Sep8 10ET; Q2QSS Sep9 10ET. Separate periods and industries; macro context not entry signal. https://www.census.gov/economic-indicators/calendar-listview.html
ASO September9 before-open results
Catalyst run-ups2026-09-08 08:03
Aug26issuer Q2FY26Sep9beforeopen,10ETcall; recheckedSep8. https://investors.academy.com/news-releases/news-release-details/academy-sports-outdoors-announces-second-quarter-fiscal-2026
CHWY September9 before-open results
Catalyst run-ups2026-09-08 08:03
Aug19issuer Q2Sep9beforeopen,08ETcall; exactfirstrelease minute unknown,recheckedSep8. https://investor.chewy.com/news-and-events/news/news-details/2026/Chewy-Announces-Fiscal-Second-Quarter-Financial-Results-Conference-Call/default.aspx
GME Preannounced Q2 complete results September8
Catalyst run-ups2026-09-08 08:03
Aug31issuer expectsSep8 complete results dateonly; sales780–800m,operating150–170m,net290–310m,netinvestment gain238m lessdigital75m; period13weeksAug1. Alreadypublicnotfresh surprise; do not equate netprofit with retail earnings. https://investor.gamestop.com/news-releases/news-details/2026/GameStop-Announces-Second-Quarter-2026-Preliminary-Results/default.aspx
CASY September8 release and September9 call
Catalyst run-ups2026-09-08 08:03
IssuerAug19 PDF now accessible: Q1FY27 Sep8afterclose; Sep9 07:30Central=08:30ETcall. Closes prior PDFaccessgap. No firstrelease minute. https://investor.caseys.com/node/17571/pdf
BRZE September8 after-close earnings
Catalyst run-ups2026-09-08 08:03
IssuerAug18 Q2FY27 afterclose Sep8,16:30ETcall. ReverifiedSep8 08UTC. https://investors.braze.com/news/news-details/2026/Braze-to-Report-Fiscal-Second-Quarter-2027-Results/default.aspx
AVO September8 after-close earnings
Catalyst run-ups2026-09-08 08:03
Issuer Aug25 confirmsSep8afterclose,17ETcall. Source literally says quarterendedJuly30; preserve as written, do not silently substituteJuly31. One regularsession remains, firstnews minute unconfirmed. https://investors.missionproduce.com/news-releases/news-release-details/mission-producer-release-fiscal-third-quarter-2026-financial
UPB VALIANT topline already public February11 = 478
Catalyst run-ups2026-09-08 08:03
Issuer Feb11 2026, phase2 up to60weeks N478; AAER56% p<.0003 at100mgq12w and39% p<.02 at400mgq24w; FEV1+122/+139mL. Sponsor source promotional; Sept8 07:55news is presentation lead, not verified new topline. Direct current IR index latestSep1 as accessed08UTC; cannot exclude unindexed release. https://investors.upstreambio.com/news-releases/news-release-details/upstream-bio-reports-positive-top-line-results-phase-2-valiant
NewerPage 95 of 158Older